ASSERTIO THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
ASSERTIO THERAPEUTICS, INC. had Finite-Lived Intangible Asset, Expected Amortization, Year One of $101.77 million as of 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2019-03-11
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $101.77M.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $101.77M.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $102.94M.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $108.15M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2018-12-31 | $101.77M 10-K · filed 2019-03-11 |
| 2017-12-31 | $101.77M 10-K · filed 2018-03-01 |
| 2016-12-31 | $102.94M 10-K · filed 2017-02-24 |
| 2015-12-31 | $108.15M 10-K · filed 2016-02-26 |
| 2014-12-31 | $10.20M 10-K · filed 2015-02-26 |